Superworth

Tactile Systems Technology price to sales ratio TCMD

Market value divided by revenue over the last twelve months, since 2017.

Today, Nov 2, 2026
1.5×
10-year median
2.1×
Against its 10-year history
33rd
percentile: 0 is its lowest day, 100 its highest
10-year range
0.6× to 10.5×
Peer median
1.9×

Tactile Systems Technology's price to sales ratio is 1.5× as of Nov 2, 2026.

That is below its ten-year median of 2.1×, lower than on 67% of days in the last ten years.

Over that time it ranged from 0.6× in Oct 2022 to 10.5× in Sep 2018.

The median for 10 medical instruments and supplies stocks of a similar size is 1.9×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.5×1.4×2.2×
20252.1×0.7×2.1×
20241.5×1.0×1.6×
20231.2×0.9×2.2×
20221.0×0.6×2.1×
20211.8×1.8×6.6×
20204.7×3.1×7.4×
20197.3×4.9×10.4×
20186.1×4.8×10.5×
20175.0×3.5×6.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest Tactile Systems Technology's size, closest first, today.

CompanyPrice to sales ratio
TCMDTactile Systems Technology1.5×
MOVMovado1.0×
EMBCEmbecta0.3×
INFUInfuSystem1.9×
IRMDIradimed11.4×
IARTIntegra Lifesciences0.6×
BVSBioventus1.9×
UTMDUtah Medical Products6.2×
STAAStaar Surgical3.7×
CDRECadre2.0×
EYENational Vision0.7×
Peer median1.9×

Where Tactile Systems Technology ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Tactile Systems Technology

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.